Prostate-specific antigen screening at low thresholds of men with pathogenic BRCA1/2 variants
Prostate Cancer and Prostatic Diseases – Prostate-specific antigen screening at low thresholds of men with pathogenic BRCA1/2 variants
Related Articles
Early Diagnosis and Treatment Are Critical in Achieving the Best Outcomes in Sarcoma
Breelyn Wilky, MD, discusses the importance of disease screening and early diagnosis in the treatment of patients with sarcoma.
Obe-Cel Produces Durable Remissions in Adult R/R B-ALL
Obe-cel generated durable remissions in patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated during the FELIX trial.
Lete-Cel Receives FDA Breakthrough Therapy Designation for Advanced Myxoid/Round Cell Liposarcoma
The FDA granted breakthrough therapy designation to lete-cel for patients with unresectable or metastatic myxoid/round cell liposarcoma.
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms
Nature Communications – Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis involving evasion of immune control. Here, the authors perform a comprehensive analysis of single-cell…
Children’s arithmetic skills do not transfer between applied and academic mathematics
Nature – Children who learn maths working in markets and children who learn maths only from school were both unable to transfer their skills to…
Dr Levy on the Development and Clinical Use of ADCs in NSCLC
Benjamin P. Levy, MD, discusses the current clinical and developmental statuses of several ADCs for patients with non–small cell lung cancer.
COMFORT Studies in Context: Understanding Response Parameters and Long-Term Outcomes
Panelists discuss how the landmark COMFORT trials have shaped the understanding of Janus kinase inhibitor therapy response criteria and long-term clinical outcomes in patients with…
Quantitative IHC Assays May Bridge Gaps in Breast Cancer IHC Test Concordance
David Rimm, MD, PhD, discusses pathology limitations that have been exacerbated by the current lineup of breast cancer IHC tests.
MCU expression in hippocampal CA2 neurons modulates dendritic mitochondrial morphology and synaptic plasticity
Scientific Reports – MCU expression in hippocampal CA2 neurons modulates dendritic mitochondrial morphology and synaptic plasticity
Precision Medicine Heats Up Ahead of SOGO Annual Meeting in GI Cancer
E. Gabriela Chiorean, MD, FASCO, discusses exciting targeted therapies in the GI space and topics to be discussed at the School of Gastrointestinal Oncology meeting.